Financial Overview
Here you will find a summary of Eli Lilly and Company's latest financial information.
| Latest Earnings Release and 10-Q | Date Filed | Format | Size | |
|---|---|---|---|---|
| First Quarter Financial Results |  |
N/A | ||
| Form 10-Q | May 1, 2009 | 
|
468.6 KB | |
| Latest Annual Report and 10-K | Date Filed | Format | Size | |
| Annual Report and Proxy Statement |
|
1.7 MB | ||
| Form 10-K | Feb 27, 2009 |
|
1.7 MB | |
| Form 10-K/A | Oct 21, 2008 |
|
1.0 MB | |
| Latest Proxy Statement | Date Filed | Format | Size | |
| Proxy Statement (DEFA14A) | Mar 17, 2009 |
|
28.9 KB | |
| Share Related Items | |
|---|---|
| Market Cap. (Mil) $ | 40,169.580 |
| Shares Out (Mil) | 1,149.016 |
| Float (Mil) | 1,003.300 |
Enrollment for Electronic Document Delivery of Proxy and related materials for shareholders.
Share Related information provided by Reuters.Data as of Jul 1, 2009.
Mil=Millions
Stock Information
| NYSE:LLY
$34.01 - 0.95 |
Jul 2, 2009
4:15 PM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.
